Intramuscular Dexamethasone for Pediatric Acute Urticaria
Intramuscular dexamethasone (Decadron) is not recommended as first-line treatment for uncomplicated acute urticaria in children—oral antihistamines alone are the evidence-based standard, and adding systemic corticosteroids provides minimal to no additional benefit while increasing adverse effects.
Treatment Algorithm for Pediatric Acute Urticaria
First-Line Treatment
- Start with a second-generation H1-antihistamine (e.g., cetirizine, loratadine) at standard dosing 1
- If symptoms are intolerable or severe, consider adding an H2-antihistamine (e.g., ranitidine), though evidence for added benefit is limited 1
- Avoid first-generation sedating antihistamines as routine first-line therapy—they offer no proven advantage over non-sedating options 2
When Corticosteroids May Be Considered
The evidence for systemic corticosteroids in acute urticaria is contradictory and context-dependent:
Arguments AGAINST routine corticosteroid use:
- A 2021 RCT found no improvement in pruritus at 60 minutes when IV dexamethasone was added to chlorpheniramine, and oral prednisolone continuation was associated with more persistent urticaria activity at 1 week and 1 month 3
- A 2024 meta-analysis showed corticosteroids likely improve urticaria activity by only 2.2% absolute difference in patients with high antihistamine responsiveness (NNT=45), while increasing adverse events by 15% (NNH=9) 4
- Recent systematic reviews conclude the addition of corticosteroids to antihistamines remains unclear and needs further investigation 5
Arguments FOR selective corticosteroid use:
- A 1995 RCT demonstrated that prednisone 20 mg twice daily for 4 days significantly reduced itch scores and improved rash resolution compared to antihistamines alone 6
- A 2024 meta-analysis found corticosteroids likely improve urticaria activity by 14-15% absolute difference (NNT=7) in patients with low-to-moderate antihistamine responsiveness 4
- Guidelines state oral corticosteroids may shorten acute urticaria duration (e.g., prednisolone 50 mg daily for 3 days in adults, with lower doses often effective) 1
Specific Recommendations for IM Dexamethasone
If corticosteroids are deemed necessary:
- Prefer oral corticosteroids (prednisolone or prednisone) over IM dexamethasone for uncomplicated acute urticaria
- Reserve parenteral corticosteroids (hydrocortisone, not dexamethasone) for severe laryngeal edema or anaphylaxis, though their action is delayed 1
- The FDA label for Decadron provides no specific pediatric dosing for acute urticaria—dosing ranges from 0.75-9 mg daily for various conditions, individualized by disease severity 7
Critical Caveats
Distinguish true indications for corticosteroids:
- Uncomplicated acute urticaria (wheals and itch only): Corticosteroids NOT routinely indicated
- Severe laryngeal angioedema or anaphylaxis: Parenteral corticosteroids indicated as adjunct (use hydrocortisone, not dexamethasone) 1
- Urticarial vasculitis or severe delayed pressure urticaria: Short tapering courses (3-4 weeks) may be necessary 1
Antihistamine optimization before adding corticosteroids:
Adverse effects matter:
Practical Clinical Approach
For a child presenting with acute urticaria (hives):
- Assess severity: Wheals and pruritus only vs. angioedema vs. anaphylaxis
- Uncomplicated acute urticaria: Start second-generation H1-antihistamine; observe response
- Severe pruritus unresponsive to antihistamines: Consider short oral corticosteroid course (e.g., prednisolone 1-2 mg/kg/day for 3-5 days, maximum 50 mg/day) only if symptoms are truly intolerable
- Angioedema with airway compromise or anaphylaxis: IM epinephrine is life-saving; add parenteral hydrocortisone as adjunct 1
IM dexamethasone specifically has no established role in routine pediatric acute urticaria management. The evidence favors oral corticosteroids when needed, and even then, only in selected cases with poor antihistamine response.